These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22707584)

  • 1. CrossTalk opposing view: Most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation.
    Lavie L; Lavie P
    J Physiol; 2012 Jun; 590(12):2817-9; discussion 2821. PubMed ID: 22707584
    [No Abstract]   [Full Text] [Related]  

  • 2. CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.
    Kohler M; Stradling JR
    J Physiol; 2012 Jun; 590(12):2813-5; discussion 2823. PubMed ID: 22707583
    [No Abstract]   [Full Text] [Related]  

  • 3. Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study.
    Bisogni V; Pengo MF; Drakatos P; Maiolino G; Kent B; Rossitto G; Steier J; Rossi GP
    Int J Cardiol; 2017 Jun; 236():458-461. PubMed ID: 28190618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.
    Thomas JJ; Ren J
    Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):995-1003. PubMed ID: 23082844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Why is obstructive sleep apnea (OSA) a cardiovascular risk factor?].
    Koehler U; Becker HF; Gross V; Reinke C; Penzel T; Schäfer H; Vogelmeier C
    Z Kardiol; 2003 Dec; 92(12):977-84. PubMed ID: 14663607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on cardiovascular effects of obstructive sleep apnoea syndrome.
    Uyar M; Davutoglu V
    Postgrad Med J; 2016 Sep; 92(1091):540-4. PubMed ID: 27317753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular morbidity associated with obstructive sleep apnea syndrome].
    Destors M; Tamisier R; Baguet JP; Levy P; Pepin JL
    Rev Mal Respir; 2014 Apr; 31(4):375-85. PubMed ID: 24750957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.
    Pack AI; Gislason T
    Prog Cardiovasc Dis; 2009; 51(5):434-51. PubMed ID: 19249449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep apnoea and hypertension: role of chemoreflexes in humans.
    Smith ML; Pacchia CF
    Exp Physiol; 2007 Jan; 92(1):45-50. PubMed ID: 17099063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms.
    Arnaud C; Bochaton T; Pépin JL; Belaidi E
    Arch Cardiovasc Dis; 2020 May; 113(5):350-358. PubMed ID: 32224049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea as a cause of neurogenic hypertension.
    Narkiewicz K; Somers VK
    Curr Hypertens Rep; 1999 Jun; 1(3):268-73. PubMed ID: 10981077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome.
    Wolf J; Hering D; Narkiewicz K
    Hypertens Res; 2010 Sep; 33(9):867-71. PubMed ID: 20818398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension and obstructive sleep apnea.
    Cai A; Wang L; Zhou Y
    Hypertens Res; 2016 Jun; 39(6):391-5. PubMed ID: 26888120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea.
    Fletcher EC
    Sleep; 2003 Feb; 26(1):15-9. PubMed ID: 12627727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities.
    McNicholas WT; Bonsigore MR;
    Eur Respir J; 2007 Jan; 29(1):156-78. PubMed ID: 17197482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension.
    Weiss JW; Liu MD; Huang J
    Exp Physiol; 2007 Jan; 92(1):21-6. PubMed ID: 17124275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity?
    Esler M; Eikelis N
    J Appl Physiol (1985); 2006 Jan; 100(1):11-2. PubMed ID: 16357080
    [No Abstract]   [Full Text] [Related]  

  • 18. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences.
    Wolf J; Lewicka J; Narkiewicz K
    Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):233-40. PubMed ID: 17314035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms in the development of cardiovascular complications in obstructive sleep apnea].
    Tomori Z; Szabóová E; Donic V; Donicová V; Tormásiová M
    Sb Lek; 2000; 101(4):375-80. PubMed ID: 11702579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea.
    Grassi G; Seravalle G; Brambilla G; Buzzi S; Volpe M; Cesana F; Dell'oro R; Mancia G
    J Hypertens; 2014 Feb; 32(2):383-8. PubMed ID: 24419212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.